What caused the IGPH.SW stock drop today?

The intraday drop to CHF 0.0015 on 05 Feb 2026 occurred with heavy volume of 2,033,000 shares. That pattern points to a liquidity-driven move and likely selling pressure rather than a single clear corporate announcement.

What is Meyka AI's view on IGPH.SW stock?

Meyka AI assigns IGPH.SW a **C+** score (58.59) with a HOLD suggestion. The grade reflects weak financials, small market cap, and sector comparison. This is informational and not investment advice.

What are realistic price targets for IGPH.SW stock?

Meyka AI's baseline 12-month target is **CHF 0.0050** (+233.33% vs CHF 0.0015). A conservative downside case is **CHF 0.0010** (-33.33%). Forecasts are projections and not guarantees.

How risky is trading IGPH.SW intraday?

High risk. The stock shows wide spreads, thin liquidity, and rapid price swings. Relative volume of 10.48x on the latest session increases execution risk and slippage for market orders.

CH Stocks

IGPH.SW IGEA Pharma (SIX) down 25% intraday 05 Feb 2026: volume spike warns

ByDanny Kontos February 5, 2026

IGPH.SW stock plunged 25.00% intraday to CHF 0.0015 on 05 Feb 2026 as trade volume surged to 2,033,000 shares. That sharp move makes IGEA Pharma N.V. (IGPH.SW) one of the most active names on the SIX Switzerland session. The decline followed a session high of CHF 0.002 and left the share price far below its 50-day average of CHF 0.00214 and 200-day average of CHF 0.00517. Intraday volatility and thin market cap warrant careful risk control for traders and investors.